KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:KPC Pharmaceuticals Inc (600422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014119
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and botanical drugs. It also offers drugs such as xuesaitong Injection, xuesaitong soft capsules, xuesaitong freeze-dried powder for injection, gastrodin capsules, acetagastrodin tablets, gastrodin tablets, colchicines tablet, fibrauretine tablets and injection, and breviscapine tablets, among others. KPC conducts research and development to develop new drugs. The company’s drugs are used for central nervous system disorder, cardiovascular disorders and malaria. It markets its products through its partners across the world. KPC is headquartered in Kunming, China.

KPC Pharmaceuticals Inc (600422) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Rani Therapeutics Raises Funds in Financing 12
Partnerships 14
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
Equity Offering 17
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
Debt Offering 20
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
Acquisition 22
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun’nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc – Key Competitors 30
KPC Pharmaceuticals Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPC Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KPC Pharmaceuticals Inc, Medical Devices Deals, 2011 to YTD 2017 9
KPC Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rani Therapeutics Raises Funds in Financing 12
KPC Pharma to Form Joint Venture 14
Kunming Pharma Forms Joint Venture With Uzfarmprom State Joint Stock Company 15
Kunming Pharma Enters Into Co-Development Agreement With Heilongjiang ZBD Pharma 16
KPC Pharma Receives Approval for Private Placement of Shares 17
Kunming Pharma Plans to Raise USD203 Million in Private Placement Of Shares 18
Kunming Pharma Announces Public Offering Of Shares For US$110 Million 19
KPC Pharma to Raise USD48 Million in Public Offering of Bonds 20
Kunming Pharma Plans to Raise USD49 Million in Public Offering of Bonds 21
KPC Pharma Plans to Acquire 60% Stake in Dali Based Pharma Company for USD2.7 Million 22
KPC Pharma to Acquire 60% Stake in Yun'nan-Based Pharma Company for USD3 Million 23
KPC Pharma to Acquire 70% Stake in Zhejiang Holley Nanhu Pharma from Beijing Holley-Cotec Pharma for USD4 Million 24
KPC Pharma Acquires 70% Stake in Beijing Hua Fang Ketai Pharma for USD39 Million 25
KPC Pharma Plans to Acquire Chongqing based Pharma Company from Beijing based Medical Company for USD8 Million 26
KPC Pharma Plans to Acquire Beijing based Pharma Company for USD1.4 Million 27
KPC Pharma Acquires 49% Stake in Kunming-based Pharma Company from Kunming Baker Norton Pharma for USD48 Million 28
KPC Pharma to Acquire Stake in Rani Therapeutics for USD5 Million 29
KPC Pharmaceuticals Inc, Key Competitors 30
KPC Pharmaceuticals Inc, Subsidiaries 31
KPC Pharmaceuticals Inc, Joint Venture 31

★海外企業調査レポート[KPC Pharmaceuticals Inc (600422)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • MLM Biologics Inc:企業の製品パイプライン分析2018
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full thicknes …
  • 4P-Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary 4P-Pharma SAS (4P-Pharma) is a drug development company that offers drug pipeline for cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets therap …
  • Purdue Pharma L.P.:企業のM&A・事業提携・投資動向
    Purdue Pharma L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Purdue Pharma L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Everest Re Group, Ltd.:企業の戦略・SWOT・財務分析
    Everest Re Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Everest Re Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. …
  • Abengoa SA (ABG):電力:M&Aディール及び事業提携情報
    Summary Abengoa SA (Abengoa) is an applied engineering and equipment manufacturer. It employs novel technological solutions for sustainability in infrastructures, energy and water sectors. The company provides integrated project solutions. Abengoa’s solutions include engineering, and operation and m …
  • CCM Duopharma Biotech Bhd (CCMDBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary CCM Duopharma Biotech Bhd (CCMD), a subsidiary of Chemical Company of Malaysia Bhd, is a pharmaceutical company that develops, manufactures and markets generic drugs and branded pharmaceutical products. The company offers products in the form of tablets, capsules, syrup, oral antibiotic, cre …
  • Orgenesis Inc (ORGS):製薬・医療:M&Aディール及び事業提携情報
    Summary Orgenesis Inc (Orgenesis) is a biopharmaceutical company that focuses on the development and manufacturing of regenerative cellular therapy and medicine for the treatment of insulin-dependent diabetes patients. The company, through its subsidiaries, offers contract development and manufactur …
  • XPO Logistics, Inc.:企業のM&A・事業提携・投資動向
    XPO Logistics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's XPO Logistics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Federal Electricity & Water Authority:電力:M&Aディール及び事業提携情報
    Summary Federal Electricity & Water Authority (FEWA) owned by the Ministry of Electricity and Water, is an energy utility that produces electricity and distillates sea water. It generates electricity from natural gas; and distillates water in multiple effect distillation (MED) and reverse osmosis (R …
  • Shandong Dongming Petrochemical Group Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Shandong Dongming Petrochemical Group Co Ltd (Dongming Petrochemical) is a chemicals manufacturing company that offers chemicals and petrochemicals. The group’s products include gasoline, diesel, LPG, solvent oil, liquid paraffin, polypropylene, high-grade road asphalt, petroleum refining pr …
  • Northern Technologies International Corp (NTIC):企業の財務・戦略的SWOT分析
    Northern Technologies International Corp (NTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • Lumberg Connect GmbH:企業の戦略的SWOT分析
    Lumberg Connect GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GrabTaxi Holdings Pte Ltd:企業の戦略的SWOT分析
    GrabTaxi Holdings Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dev Information Technology Limited (DEVIT):企業の財務・戦略的SWOT分析
    Dev Information Technology Limited (DEVIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Samsung Electronics Co Ltd.:企業の戦略・SWOT・財務分析
    Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Electronics Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆